Find your next paid study

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well da…